1. A population‐based study of chronic myeloid leukemia patients treated with imatinib in first line. Issue 1 (18th November 2016) Authors: Castagnetti, Fausto; Di Raimondo, Francesco; De Vivo, Antonio; Spitaleri, Antonio; Gugliotta, Gabriele; Fabbiano, Francesco; Capodanno, Isabella; Mannina, Donato; Salvucci, Marzia; Antolino, Agostino; Marasca, Roberto; Musso, Maurizio; Crugnola, Monica; Impera, Stefana; Trabacchi, Elena; Musolino... Journal: American journal of hematology Issue: Volume 92:Issue 1(2017:Jan.) Page Start: 82 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Impact of comorbidities on the treatment of chronic myeloid leukemia with tyrosine-kinase inhibitors. Issue 5 (October 2013) Authors: Gugliotta, Gabriele; Castagnetti, Fausto; Fogli, Miriam; Cavo, Michele; Baccarani, Michele; Rosti, Gianantonio Journal: Expert review of hematology Issue: Volume 6:Issue 5(2013) Page Start: 563 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Long term outcome of Ph+ CML patients achieving complete cytogenetic remission with interferon based therapy moving from interferon to imatinib era. Issue 2 (February 2014) Authors: Malagola, Michele; Breccia, Massimo; Skert, Cristina; Cancelli, Valeria; Soverini, Simona; Iacobucci, Ilaria; Cattina, Federica; Liberati, Anna Maria; Tiribelli, Mario; Annunziata, Mario; Trabacchi, Elena; De, Antonio; Castagnetti, Fausto; Martinelli, Giovanni; Fogli, Miriam; Stagno, Fabio; Pica,... Journal: American journal of hematology Issue: Volume 89:Issue 2(2014:Feb.) Page Start: 119 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗